Clinical Trials Logo

Clinical Trial Summary

The study hypothesis is that DHA is more effective than placebo in increasing brain activation and reducing symptoms in psychostimulant-free children with ADHD.


Clinical Trial Description

This study aims to determine the effects of 10-week dietary supplementation with the long-chain omega-3 fatty acid docosahexaenoic acid (DHA) or placebo on prefrontal cortical structural and functional connectivity using several neuroimaging techniques: DTI (Diffusion Tensor Imaging), 1H MRS(Proton Magnetic Resonance Spectroscopy), and fMRI (Functional Magnetic Resonance Imaging) in psychostimulant-free children with attention deficit hyperactivity disorder (ADHD). It is postulated that DHA supplements will increase brain activation and reduce ADHD symptomatology. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01883817
Study type Interventional
Source University of Cincinnati
Contact
Status Completed
Phase Phase 3
Start date September 2013
Completion date March 3, 2017

See also
  Status Clinical Trial Phase
Completed NCT03662763 - Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity Phase 3
Recruiting NCT01154686 - Working Memory Training in College Students With Attention-Deficit Hyperactivity Disorder/Learning Disabilities N/A
Unknown status NCT01130467 - Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder Phase 4
Completed NCT04577417 - Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD
Completed NCT03948607 - Neural Mechanisms of Attention Lapses in Adult ADHD
Completed NCT06064942 - Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT06030024 - Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder N/A
Completed NCT05096975 - Personality Profile of Children and Adolescents With ADHD and With or Without Emotional Dysregulation
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT02062411 - A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder N/A
Completed NCT01000064 - Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits Phase 3
Completed NCT00048360 - Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Phase 3
Completed NCT00776737 - Studies of Measures of Attention N/A
Recruiting NCT05243186 - Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill Phase 2/Phase 3
Recruiting NCT05133284 - Effectiveness of a Therapeutic Education Program in Improving Quality of Life of Children With ADHD and Their Parents
Completed NCT02635035 - Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT Phase 2
Completed NCT01369459 - Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder Phase 1
Recruiting NCT05406414 - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems N/A
Not yet recruiting NCT06248229 - A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD). Phase 4